nodes	percent_of_prediction	percent_of_DWPC	metapath
Polythiazide—Dermatitis—Crizotinib—lung cancer	0.00463	0.00463	CcSEcCtD
Polythiazide—Diarrhoea—Pemetrexed—lung cancer	0.00459	0.00459	CcSEcCtD
Polythiazide—Vertigo—Vinblastine—lung cancer	0.00457	0.00457	CcSEcCtD
Polythiazide—Diarrhoea—Gefitinib—lung cancer	0.00456	0.00456	CcSEcCtD
Polythiazide—Leukopenia—Vinblastine—lung cancer	0.00455	0.00455	CcSEcCtD
Polythiazide—Pancreatitis—Cisplatin—lung cancer	0.00445	0.00445	CcSEcCtD
Polythiazide—Dizziness—Pemetrexed—lung cancer	0.00444	0.00444	CcSEcCtD
Polythiazide—Leukopenia—Topotecan—lung cancer	0.00442	0.00442	CcSEcCtD
Polythiazide—Hyperglycaemia—Gemcitabine—lung cancer	0.00439	0.00439	CcSEcCtD
Polythiazide—Nausea—Crizotinib—lung cancer	0.00436	0.00436	CcSEcCtD
Polythiazide—Jaundice—Irinotecan—lung cancer	0.00435	0.00435	CcSEcCtD
Polythiazide—Cramp muscle—Etoposide—lung cancer	0.00433	0.00433	CcSEcCtD
Polythiazide—Urticaria—Teniposide—lung cancer	0.00432	0.00432	CcSEcCtD
Polythiazide—Orthostatic hypotension—Paclitaxel—lung cancer	0.00431	0.00431	CcSEcCtD
Polythiazide—Hyperuricaemia—Methotrexate—lung cancer	0.00428	0.00428	CcSEcCtD
Polythiazide—Vomiting—Pemetrexed—lung cancer	0.00427	0.00427	CcSEcCtD
Polythiazide—Cramp muscle—Paclitaxel—lung cancer	0.00425	0.00425	CcSEcCtD
Polythiazide—Glycosuria—Doxorubicin—lung cancer	0.00424	0.00424	CcSEcCtD
Polythiazide—Vomiting—Gefitinib—lung cancer	0.00424	0.00424	CcSEcCtD
Polythiazide—Rash—Pemetrexed—lung cancer	0.00423	0.00423	CcSEcCtD
Polythiazide—Dermatitis—Pemetrexed—lung cancer	0.00423	0.00423	CcSEcCtD
Polythiazide—Rash—Gefitinib—lung cancer	0.00421	0.00421	CcSEcCtD
Polythiazide—Dermatitis—Gefitinib—lung cancer	0.0042	0.0042	CcSEcCtD
Polythiazide—Vasculitis—Methotrexate—lung cancer	0.00407	0.00407	CcSEcCtD
Polythiazide—Thrombocytopenia—Vinblastine—lung cancer	0.00406	0.00406	CcSEcCtD
Polythiazide—Agranulocytosis—Gemcitabine—lung cancer	0.00405	0.00405	CcSEcCtD
Polythiazide—Blood uric acid increased—Methotrexate—lung cancer	0.00404	0.00404	CcSEcCtD
Polythiazide—Hypersensitivity—Teniposide—lung cancer	0.00401	0.00401	CcSEcCtD
Polythiazide—Pancreatitis—Paclitaxel—lung cancer	0.004	0.004	CcSEcCtD
Polythiazide—Nausea—Pemetrexed—lung cancer	0.00399	0.00399	CcSEcCtD
Polythiazide—Nausea—Gefitinib—lung cancer	0.00396	0.00396	CcSEcCtD
Polythiazide—Anorexia—Vinblastine—lung cancer	0.00396	0.00396	CcSEcCtD
Polythiazide—Thrombocytopenia—Topotecan—lung cancer	0.00395	0.00395	CcSEcCtD
Polythiazide—Jaundice cholestatic—Doxorubicin—lung cancer	0.00391	0.00391	CcSEcCtD
Polythiazide—Thrombocytopenia—Erlotinib—lung cancer	0.0039	0.0039	CcSEcCtD
Polythiazide—Asthenia—Teniposide—lung cancer	0.0039	0.0039	CcSEcCtD
Polythiazide—Anorexia—Topotecan—lung cancer	0.00384	0.00384	CcSEcCtD
Polythiazide—Anorexia—Erlotinib—lung cancer	0.0038	0.0038	CcSEcCtD
Polythiazide—Vertigo—Vinorelbine—lung cancer	0.0038	0.0038	CcSEcCtD
Polythiazide—Leukopenia—Vinorelbine—lung cancer	0.00378	0.00378	CcSEcCtD
Polythiazide—Aplastic anaemia—Methotrexate—lung cancer	0.00373	0.00373	CcSEcCtD
Polythiazide—Paraesthesia—Vinblastine—lung cancer	0.00373	0.00373	CcSEcCtD
Polythiazide—Photosensitivity reaction—Paclitaxel—lung cancer	0.00372	0.00372	CcSEcCtD
Polythiazide—Diarrhoea—Teniposide—lung cancer	0.00372	0.00372	CcSEcCtD
Polythiazide—Hyperuricaemia—Doxorubicin—lung cancer	0.00371	0.00371	CcSEcCtD
Polythiazide—Hyperglycaemia—Paclitaxel—lung cancer	0.00368	0.00368	CcSEcCtD
Polythiazide—Orthostatic hypotension—Docetaxel—lung cancer	0.00365	0.00365	CcSEcCtD
Polythiazide—Paraesthesia—Topotecan—lung cancer	0.00362	0.00362	CcSEcCtD
Polythiazide—Jaundice—Etoposide—lung cancer	0.00362	0.00362	CcSEcCtD
Polythiazide—Decreased appetite—Vinblastine—lung cancer	0.00361	0.00361	CcSEcCtD
Polythiazide—Cramp muscle—Docetaxel—lung cancer	0.0036	0.0036	CcSEcCtD
Polythiazide—Constipation—Vinblastine—lung cancer	0.00355	0.00355	CcSEcCtD
Polythiazide—Decreased appetite—Topotecan—lung cancer	0.0035	0.0035	CcSEcCtD
Polythiazide—Blood uric acid increased—Doxorubicin—lung cancer	0.0035	0.0035	CcSEcCtD
Polythiazide—Decreased appetite—Erlotinib—lung cancer	0.00347	0.00347	CcSEcCtD
Polythiazide—Agranulocytosis—Etoposide—lung cancer	0.00346	0.00346	CcSEcCtD
Polythiazide—Vomiting—Teniposide—lung cancer	0.00346	0.00346	CcSEcCtD
Polythiazide—Constipation—Topotecan—lung cancer	0.00345	0.00345	CcSEcCtD
Polythiazide—Rash—Teniposide—lung cancer	0.00343	0.00343	CcSEcCtD
Polythiazide—Dermatitis—Teniposide—lung cancer	0.00343	0.00343	CcSEcCtD
Polythiazide—Constipation—Erlotinib—lung cancer	0.00341	0.00341	CcSEcCtD
Polythiazide—Headache—Teniposide—lung cancer	0.00341	0.00341	CcSEcCtD
Polythiazide—Thrombocytopenia—Vinorelbine—lung cancer	0.00338	0.00338	CcSEcCtD
Polythiazide—Muscle spasms—Irinotecan—lung cancer	0.00335	0.00335	CcSEcCtD
Polythiazide—Anorexia—Vinorelbine—lung cancer	0.00329	0.00329	CcSEcCtD
Polythiazide—Photosensitivity—Methotrexate—lung cancer	0.00328	0.00328	CcSEcCtD
Polythiazide—Nausea—Teniposide—lung cancer	0.00323	0.00323	CcSEcCtD
Polythiazide—Aplastic anaemia—Doxorubicin—lung cancer	0.00323	0.00323	CcSEcCtD
Polythiazide—Urticaria—Topotecan—lung cancer	0.0032	0.0032	CcSEcCtD
Polythiazide—Vertigo—Irinotecan—lung cancer	0.00313	0.00313	CcSEcCtD
Polythiazide—Leukopenia—Irinotecan—lung cancer	0.00312	0.00312	CcSEcCtD
Polythiazide—Paraesthesia—Vinorelbine—lung cancer	0.0031	0.0031	CcSEcCtD
Polythiazide—Hypersensitivity—Vinblastine—lung cancer	0.00306	0.00306	CcSEcCtD
Polythiazide—Muscle spasms—Cisplatin—lung cancer	0.00304	0.00304	CcSEcCtD
Polythiazide—Leukopenia—Gemcitabine—lung cancer	0.00304	0.00304	CcSEcCtD
Polythiazide—Jaundice—Docetaxel—lung cancer	0.003	0.003	CcSEcCtD
Polythiazide—Decreased appetite—Vinorelbine—lung cancer	0.003	0.003	CcSEcCtD
Polythiazide—Asthenia—Vinblastine—lung cancer	0.00298	0.00298	CcSEcCtD
Polythiazide—Hypersensitivity—Topotecan—lung cancer	0.00297	0.00297	CcSEcCtD
Polythiazide—Constipation—Vinorelbine—lung cancer	0.00295	0.00295	CcSEcCtD
Polythiazide—Asthenia—Topotecan—lung cancer	0.00289	0.00289	CcSEcCtD
Polythiazide—Agranulocytosis—Docetaxel—lung cancer	0.00288	0.00288	CcSEcCtD
Polythiazide—Asthenia—Erlotinib—lung cancer	0.00286	0.00286	CcSEcCtD
Polythiazide—Photosensitivity—Doxorubicin—lung cancer	0.00284	0.00284	CcSEcCtD
Polythiazide—Diarrhoea—Vinblastine—lung cancer	0.00284	0.00284	CcSEcCtD
Polythiazide—Leukopenia—Cisplatin—lung cancer	0.00283	0.00283	CcSEcCtD
Polythiazide—Vascular purpura—Doxorubicin—lung cancer	0.00279	0.00279	CcSEcCtD
Polythiazide—Muscle spasms—Etoposide—lung cancer	0.00279	0.00279	CcSEcCtD
Polythiazide—Thrombocytopenia—Irinotecan—lung cancer	0.00278	0.00278	CcSEcCtD
Polythiazide—Diarrhoea—Topotecan—lung cancer	0.00276	0.00276	CcSEcCtD
Polythiazide—Dizziness—Vinblastine—lung cancer	0.00274	0.00274	CcSEcCtD
Polythiazide—Urticaria—Vinorelbine—lung cancer	0.00274	0.00274	CcSEcCtD
Polythiazide—Muscle spasms—Paclitaxel—lung cancer	0.00273	0.00273	CcSEcCtD
Polythiazide—Diarrhoea—Erlotinib—lung cancer	0.00273	0.00273	CcSEcCtD
Polythiazide—Thrombocytopenia—Gemcitabine—lung cancer	0.00271	0.00271	CcSEcCtD
Polythiazide—Anorexia—Irinotecan—lung cancer	0.00271	0.00271	CcSEcCtD
Polythiazide—Dizziness—Topotecan—lung cancer	0.00267	0.00267	CcSEcCtD
Polythiazide—Anorexia—Gemcitabine—lung cancer	0.00264	0.00264	CcSEcCtD
Polythiazide—Vomiting—Vinblastine—lung cancer	0.00264	0.00264	CcSEcCtD
Polythiazide—Dizziness—Erlotinib—lung cancer	0.00264	0.00264	CcSEcCtD
Polythiazide—Agitation—Paclitaxel—lung cancer	0.00261	0.00261	CcSEcCtD
Polythiazide—Vertigo—Etoposide—lung cancer	0.0026	0.0026	CcSEcCtD
Polythiazide—Headache—Vinblastine—lung cancer	0.0026	0.0026	CcSEcCtD
Polythiazide—Leukopenia—Etoposide—lung cancer	0.00259	0.00259	CcSEcCtD
Polythiazide—Purpura—Doxorubicin—lung cancer	0.00259	0.00259	CcSEcCtD
Polythiazide—Vomiting—Topotecan—lung cancer	0.00256	0.00256	CcSEcCtD
Polythiazide—Paraesthesia—Irinotecan—lung cancer	0.00255	0.00255	CcSEcCtD
Polythiazide—Vertigo—Paclitaxel—lung cancer	0.00255	0.00255	CcSEcCtD
Polythiazide—Leukopenia—Paclitaxel—lung cancer	0.00254	0.00254	CcSEcCtD
Polythiazide—Rash—Topotecan—lung cancer	0.00254	0.00254	CcSEcCtD
Polythiazide—Hypersensitivity—Vinorelbine—lung cancer	0.00254	0.00254	CcSEcCtD
Polythiazide—Dermatitis—Topotecan—lung cancer	0.00254	0.00254	CcSEcCtD
Polythiazide—Vomiting—Erlotinib—lung cancer	0.00254	0.00254	CcSEcCtD
Polythiazide—Thrombocytopenia—Cisplatin—lung cancer	0.00253	0.00253	CcSEcCtD
Polythiazide—Headache—Topotecan—lung cancer	0.00253	0.00253	CcSEcCtD
Polythiazide—Rash—Erlotinib—lung cancer	0.00251	0.00251	CcSEcCtD
Polythiazide—Dermatitis—Erlotinib—lung cancer	0.00251	0.00251	CcSEcCtD
Polythiazide—Headache—Erlotinib—lung cancer	0.0025	0.0025	CcSEcCtD
Polythiazide—Paraesthesia—Gemcitabine—lung cancer	0.00249	0.00249	CcSEcCtD
Polythiazide—Asthenia—Vinorelbine—lung cancer	0.00247	0.00247	CcSEcCtD
Polythiazide—Decreased appetite—Irinotecan—lung cancer	0.00247	0.00247	CcSEcCtD
Polythiazide—Nausea—Vinblastine—lung cancer	0.00246	0.00246	CcSEcCtD
Polythiazide—Anorexia—Cisplatin—lung cancer	0.00246	0.00246	CcSEcCtD
Polythiazide—Pancreatitis—Methotrexate—lung cancer	0.00244	0.00244	CcSEcCtD
Polythiazide—Constipation—Irinotecan—lung cancer	0.00243	0.00243	CcSEcCtD
Polythiazide—Decreased appetite—Gemcitabine—lung cancer	0.00241	0.00241	CcSEcCtD
Polythiazide—Nausea—Topotecan—lung cancer	0.00239	0.00239	CcSEcCtD
Polythiazide—Constipation—Gemcitabine—lung cancer	0.00237	0.00237	CcSEcCtD
Polythiazide—Nausea—Erlotinib—lung cancer	0.00237	0.00237	CcSEcCtD
Polythiazide—Diarrhoea—Vinorelbine—lung cancer	0.00236	0.00236	CcSEcCtD
Polythiazide—Paraesthesia—Cisplatin—lung cancer	0.00232	0.00232	CcSEcCtD
Polythiazide—Thrombocytopenia—Etoposide—lung cancer	0.00232	0.00232	CcSEcCtD
Polythiazide—Muscle spasms—Docetaxel—lung cancer	0.00232	0.00232	CcSEcCtD
Polythiazide—Dizziness—Vinorelbine—lung cancer	0.00228	0.00228	CcSEcCtD
Polythiazide—Orthostatic hypotension—Doxorubicin—lung cancer	0.00228	0.00228	CcSEcCtD
Polythiazide—Photosensitivity reaction—Methotrexate—lung cancer	0.00227	0.00227	CcSEcCtD
Polythiazide—Thrombocytopenia—Paclitaxel—lung cancer	0.00227	0.00227	CcSEcCtD
Polythiazide—Anorexia—Etoposide—lung cancer	0.00225	0.00225	CcSEcCtD
Polythiazide—Decreased appetite—Cisplatin—lung cancer	0.00224	0.00224	CcSEcCtD
Polythiazide—Anorexia—Paclitaxel—lung cancer	0.00221	0.00221	CcSEcCtD
Polythiazide—Vomiting—Vinorelbine—lung cancer	0.00219	0.00219	CcSEcCtD
Polythiazide—Rash—Vinorelbine—lung cancer	0.00217	0.00217	CcSEcCtD
Polythiazide—Dermatitis—Vinorelbine—lung cancer	0.00217	0.00217	CcSEcCtD
Polythiazide—Headache—Vinorelbine—lung cancer	0.00216	0.00216	CcSEcCtD
Polythiazide—Leukopenia—Docetaxel—lung cancer	0.00216	0.00216	CcSEcCtD
Polythiazide—Paraesthesia—Etoposide—lung cancer	0.00212	0.00212	CcSEcCtD
Polythiazide—Pancreatitis—Doxorubicin—lung cancer	0.00212	0.00212	CcSEcCtD
Polythiazide—Hypersensitivity—Irinotecan—lung cancer	0.0021	0.0021	CcSEcCtD
Polythiazide—Paraesthesia—Paclitaxel—lung cancer	0.00208	0.00208	CcSEcCtD
Polythiazide—Agranulocytosis—Methotrexate—lung cancer	0.00207	0.00207	CcSEcCtD
Polythiazide—Decreased appetite—Etoposide—lung cancer	0.00206	0.00206	CcSEcCtD
Polythiazide—Nausea—Vinorelbine—lung cancer	0.00205	0.00205	CcSEcCtD
Polythiazide—Asthenia—Irinotecan—lung cancer	0.00204	0.00204	CcSEcCtD
Polythiazide—Constipation—Etoposide—lung cancer	0.00202	0.00202	CcSEcCtD
Polythiazide—Decreased appetite—Paclitaxel—lung cancer	0.00202	0.00202	CcSEcCtD
Polythiazide—Asthenia—Gemcitabine—lung cancer	0.00199	0.00199	CcSEcCtD
Polythiazide—Constipation—Paclitaxel—lung cancer	0.00198	0.00198	CcSEcCtD
Polythiazide—Photosensitivity reaction—Doxorubicin—lung cancer	0.00197	0.00197	CcSEcCtD
Polythiazide—Hyperglycaemia—Doxorubicin—lung cancer	0.00195	0.00195	CcSEcCtD
Polythiazide—Diarrhoea—Irinotecan—lung cancer	0.00195	0.00195	CcSEcCtD
Polythiazide—Thrombocytopenia—Docetaxel—lung cancer	0.00192	0.00192	CcSEcCtD
Polythiazide—Hypersensitivity—Cisplatin—lung cancer	0.0019	0.0019	CcSEcCtD
Polythiazide—Diarrhoea—Gemcitabine—lung cancer	0.0019	0.0019	CcSEcCtD
Polythiazide—Dizziness—Irinotecan—lung cancer	0.00188	0.00188	CcSEcCtD
Polythiazide—Urticaria—Etoposide—lung cancer	0.00188	0.00188	CcSEcCtD
Polythiazide—Jaundice—Doxorubicin—lung cancer	0.00188	0.00188	CcSEcCtD
Polythiazide—Anorexia—Docetaxel—lung cancer	0.00187	0.00187	CcSEcCtD
Polythiazide—Asthenia—Cisplatin—lung cancer	0.00185	0.00185	CcSEcCtD
Polythiazide—Urticaria—Paclitaxel—lung cancer	0.00184	0.00184	CcSEcCtD
Polythiazide—Vomiting—Irinotecan—lung cancer	0.00181	0.00181	CcSEcCtD
Polythiazide—Agranulocytosis—Doxorubicin—lung cancer	0.0018	0.0018	CcSEcCtD
Polythiazide—Rash—Irinotecan—lung cancer	0.00179	0.00179	CcSEcCtD
Polythiazide—Dermatitis—Irinotecan—lung cancer	0.00179	0.00179	CcSEcCtD
Polythiazide—Headache—Irinotecan—lung cancer	0.00178	0.00178	CcSEcCtD
Polythiazide—Diarrhoea—Cisplatin—lung cancer	0.00177	0.00177	CcSEcCtD
Polythiazide—Paraesthesia—Docetaxel—lung cancer	0.00177	0.00177	CcSEcCtD
Polythiazide—Vomiting—Gemcitabine—lung cancer	0.00176	0.00176	CcSEcCtD
Polythiazide—Rash—Gemcitabine—lung cancer	0.00175	0.00175	CcSEcCtD
Polythiazide—Dermatitis—Gemcitabine—lung cancer	0.00175	0.00175	CcSEcCtD
Polythiazide—Hypersensitivity—Etoposide—lung cancer	0.00174	0.00174	CcSEcCtD
Polythiazide—Headache—Gemcitabine—lung cancer	0.00174	0.00174	CcSEcCtD
Polythiazide—Decreased appetite—Docetaxel—lung cancer	0.00171	0.00171	CcSEcCtD
Polythiazide—Hypersensitivity—Paclitaxel—lung cancer	0.00171	0.00171	CcSEcCtD
Polythiazide—Asthenia—Etoposide—lung cancer	0.0017	0.0017	CcSEcCtD
Polythiazide—Nausea—Irinotecan—lung cancer	0.00169	0.00169	CcSEcCtD
Polythiazide—Constipation—Docetaxel—lung cancer	0.00168	0.00168	CcSEcCtD
Polythiazide—Asthenia—Paclitaxel—lung cancer	0.00166	0.00166	CcSEcCtD
Polythiazide—Nausea—Gemcitabine—lung cancer	0.00165	0.00165	CcSEcCtD
Polythiazide—Vomiting—Cisplatin—lung cancer	0.00164	0.00164	CcSEcCtD
Polythiazide—Rash—Cisplatin—lung cancer	0.00163	0.00163	CcSEcCtD
Polythiazide—Dermatitis—Cisplatin—lung cancer	0.00163	0.00163	CcSEcCtD
Polythiazide—Diarrhoea—Etoposide—lung cancer	0.00162	0.00162	CcSEcCtD
Polythiazide—Diarrhoea—Paclitaxel—lung cancer	0.00159	0.00159	CcSEcCtD
Polythiazide—Dizziness—Etoposide—lung cancer	0.00156	0.00156	CcSEcCtD
Polythiazide—Vertigo—Methotrexate—lung cancer	0.00156	0.00156	CcSEcCtD
Polythiazide—Leukopenia—Methotrexate—lung cancer	0.00155	0.00155	CcSEcCtD
Polythiazide—Dizziness—Paclitaxel—lung cancer	0.00153	0.00153	CcSEcCtD
Polythiazide—Nausea—Cisplatin—lung cancer	0.00153	0.00153	CcSEcCtD
Polythiazide—Vomiting—Etoposide—lung cancer	0.0015	0.0015	CcSEcCtD
Polythiazide—Rash—Etoposide—lung cancer	0.00149	0.00149	CcSEcCtD
Polythiazide—Dermatitis—Etoposide—lung cancer	0.00149	0.00149	CcSEcCtD
Polythiazide—Headache—Etoposide—lung cancer	0.00148	0.00148	CcSEcCtD
Polythiazide—Vomiting—Paclitaxel—lung cancer	0.00147	0.00147	CcSEcCtD
Polythiazide—Rash—Paclitaxel—lung cancer	0.00146	0.00146	CcSEcCtD
Polythiazide—Dermatitis—Paclitaxel—lung cancer	0.00146	0.00146	CcSEcCtD
Polythiazide—Headache—Paclitaxel—lung cancer	0.00145	0.00145	CcSEcCtD
Polythiazide—Hypersensitivity—Docetaxel—lung cancer	0.00145	0.00145	CcSEcCtD
Polythiazide—Muscle spasms—Doxorubicin—lung cancer	0.00145	0.00145	CcSEcCtD
Polythiazide—Asthenia—Docetaxel—lung cancer	0.00141	0.00141	CcSEcCtD
Polythiazide—Nausea—Etoposide—lung cancer	0.00141	0.00141	CcSEcCtD
Polythiazide—Thrombocytopenia—Methotrexate—lung cancer	0.00139	0.00139	CcSEcCtD
Polythiazide—Agitation—Doxorubicin—lung cancer	0.00138	0.00138	CcSEcCtD
Polythiazide—Nausea—Paclitaxel—lung cancer	0.00138	0.00138	CcSEcCtD
Polythiazide—Vertigo—Doxorubicin—lung cancer	0.00135	0.00135	CcSEcCtD
Polythiazide—Anorexia—Methotrexate—lung cancer	0.00135	0.00135	CcSEcCtD
Polythiazide—Leukopenia—Doxorubicin—lung cancer	0.00135	0.00135	CcSEcCtD
Polythiazide—Diarrhoea—Docetaxel—lung cancer	0.00135	0.00135	CcSEcCtD
Polythiazide—Dizziness—Docetaxel—lung cancer	0.0013	0.0013	CcSEcCtD
Polythiazide—Paraesthesia—Methotrexate—lung cancer	0.00127	0.00127	CcSEcCtD
Polythiazide—Vomiting—Docetaxel—lung cancer	0.00125	0.00125	CcSEcCtD
Polythiazide—Rash—Docetaxel—lung cancer	0.00124	0.00124	CcSEcCtD
Polythiazide—Dermatitis—Docetaxel—lung cancer	0.00124	0.00124	CcSEcCtD
Polythiazide—Decreased appetite—Methotrexate—lung cancer	0.00123	0.00123	CcSEcCtD
Polythiazide—Headache—Docetaxel—lung cancer	0.00123	0.00123	CcSEcCtD
Polythiazide—Thrombocytopenia—Doxorubicin—lung cancer	0.0012	0.0012	CcSEcCtD
Polythiazide—Anorexia—Doxorubicin—lung cancer	0.00117	0.00117	CcSEcCtD
Polythiazide—Nausea—Docetaxel—lung cancer	0.00117	0.00117	CcSEcCtD
Polythiazide—Urticaria—Methotrexate—lung cancer	0.00113	0.00113	CcSEcCtD
Polythiazide—Paraesthesia—Doxorubicin—lung cancer	0.0011	0.0011	CcSEcCtD
Polythiazide—Decreased appetite—Doxorubicin—lung cancer	0.00107	0.00107	CcSEcCtD
Polythiazide—Constipation—Doxorubicin—lung cancer	0.00105	0.00105	CcSEcCtD
Polythiazide—Hypersensitivity—Methotrexate—lung cancer	0.00104	0.00104	CcSEcCtD
Polythiazide—Asthenia—Methotrexate—lung cancer	0.00102	0.00102	CcSEcCtD
Polythiazide—Urticaria—Doxorubicin—lung cancer	0.000975	0.000975	CcSEcCtD
Polythiazide—Diarrhoea—Methotrexate—lung cancer	0.000969	0.000969	CcSEcCtD
Polythiazide—Dizziness—Methotrexate—lung cancer	0.000937	0.000937	CcSEcCtD
Polythiazide—Hypersensitivity—Doxorubicin—lung cancer	0.000904	0.000904	CcSEcCtD
Polythiazide—Vomiting—Methotrexate—lung cancer	0.000901	0.000901	CcSEcCtD
Polythiazide—Rash—Methotrexate—lung cancer	0.000893	0.000893	CcSEcCtD
Polythiazide—Dermatitis—Methotrexate—lung cancer	0.000893	0.000893	CcSEcCtD
Polythiazide—Headache—Methotrexate—lung cancer	0.000888	0.000888	CcSEcCtD
Polythiazide—Asthenia—Doxorubicin—lung cancer	0.00088	0.00088	CcSEcCtD
Polythiazide—Nausea—Methotrexate—lung cancer	0.000842	0.000842	CcSEcCtD
Polythiazide—Diarrhoea—Doxorubicin—lung cancer	0.000839	0.000839	CcSEcCtD
Polythiazide—Dizziness—Doxorubicin—lung cancer	0.000811	0.000811	CcSEcCtD
Polythiazide—Vomiting—Doxorubicin—lung cancer	0.00078	0.00078	CcSEcCtD
Polythiazide—Rash—Doxorubicin—lung cancer	0.000774	0.000774	CcSEcCtD
Polythiazide—Dermatitis—Doxorubicin—lung cancer	0.000773	0.000773	CcSEcCtD
Polythiazide—Headache—Doxorubicin—lung cancer	0.000769	0.000769	CcSEcCtD
Polythiazide—Nausea—Doxorubicin—lung cancer	0.000729	0.000729	CcSEcCtD
